AstraZeneca Secures Approval For Nexium(R) (esomeprazole) In Peptic Ulcer Bleeding

AstraZeneca announced that it has completed the Mutual Recognition Procedure in Europe with Sweden as Reference Member State for the use of Nexium® (esomeprazole) to prevent peptic ulcer re-bleeding in adults.1 Esomeprazole i.v. is the first proton pump inhibitor (PPI) to be indicated in Europe for prevention of re-bleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers. The i.v. treatment should be followed by oral acid suppression therapy.

More: continued here

Filed under: GastroIntestinal / Gastroentorology on May 18th, 2009